The data from 2023 shows Germany leading in the European market for hygienic or pharmaceutical articles of rubber, accounting for the highest production share at 34.2%. France closely follows with 29.24%, while Hungary remains competitive at 29.12%. Spain, Italy, and the UK have notably smaller shares, reflecting a more fragmented production capacity. Despite Italy's minimal decrease in production, its market position remains largely stable. The UK and Finland experienced significant negative growth at -11.91% and -31.03%, respectively, indicating potential structural issues within their production sectors.
Future trends suggest a potential reshaping of the market dynamics in favor of countries with tech-driven production capabilities and strategic investments in sustainability. Germany and France are expected to continue leading, driven by innovation and domestic demand. Other countries, especially those with lower production shares, might seek to enhance their competitive edge through strategic partnerships and investments in advanced manufacturing technologies.
Top countries in Sold Production of Hygienic or Pharmaceutical Articles of Rubber (Excluding Sheath Contraceptives) Share by Country (Euros)
| # | 10 Countries | Percent | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Germany | 34.2 | 2023 | +2.43% | +5.61% | View data |
| 2 | 2 France | 29.24 | 2023 | +6.72% | +7.2% | View data |
| 3 | 3 Hungary | 29.12 | 2023 | +5.25% | +6.72% | View data |
| 4 | 4 Spain | 4.57 | 2023 | +6.27% | +16.54% | View data |
| 5 | 5 Italy | 3.04 | 2023 | -1.68% | -1.06% | View data |
| 6 | 6 United Kingdom | 0.69 | 2023 | -15.95% | -11.91% | View data |
| 7 | 7 Sweden | 0.61 | 2021 | View data | ||
| 8 | 8 Poland | 0.52 | 2023 | +0.67% | +6.08% | View data |
| 9 | 9 Denmark | 0.006 | 2021 | +4.12% | -31.44% | View data |
| 10 | 10 Finland | 0 | 2023 | +98.47% | -31.03% | View data |
Latest reports
US Pharmaceuticals Market Report- Q4 2024
In the fourth quarter of 2024, the US pharmaceuticals market exhibited robust growth across various segments, driven by strategic investments, regulatory advancements, and...
Japan Pharmaceuticals Market Report- Q4 2024
The Japanese pharmaceutical industry in Q4 2024 exhibits dynamic shifts driven by government policies, market demand, and strategic innovations. The continuous rise of...
Germany Pharmaceuticals Market Report- Q4 2024
The fourth quarter of 2024 presented a multifaceted landscape for the German pharmaceuticals industry, characterized by economic pressures, regulatory changes, and evolving consumer...
India Pharmaceuticals Market Report- Q4 2024
The Indian pharmaceutical industry in Q4 2024 continues to show dynamic growth, fueled by advancements in biologics and biosimilars, substantial export activities, and...
UK Pharmaceuticals Market Report- Q4 2024
The UK Pharmaceuticals market in Q4 2024 faced a dynamic landscape shaped by economic, regulatory, and competitive factors. Amidst inflationary pressures and evolving...
France Pharmaceuticals Market Report- Q4 2024
The French pharmaceuticals market in the fourth quarter of 2024 was marked by significant developments across various segments, including biopharmaceuticals, generic drugs, over-the-counter...
Canada Pharmaceuticals Market Report- Q4 2024
In the fourth quarter of 2024, the Canadian pharmaceuticals market showcased dynamic growth and adaptation across various segments. The evolving landscape was influenced...
Brazil Pharmaceuticals Market Report- Q4 2024
The Brazil pharmaceuticals market in Q4 2024 is characterized by significant trends and strategic developments across various segments. The demand for generic pharmaceuticals...
Italy Pharmaceuticals Market Report- Q4 2024
The fourth quarter of 2024 presents a dynamic landscape for the pharmaceuticals market in Italy, characterized by significant trends and strategic developments across...
South Korea Pharmaceuticals Market Report- Q1 2025
The first quarter of 2025 has been pivotal for the pharmaceuticals industry in South Korea, marked by significant growth in the biopharmaceuticals and...